Traded Feb 24 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 6, 2026 · Filed Feb 10, 2026
A Timken director sold $3.22M of Timken shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$3,217,543
Shares × reported transaction price
2 days after results of Feb 4, 2026, 89 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.5% | −0.8% | −0.6% |
| 30 days | −10.4% | −4.3% | −6.1% |
| 90 days | +7.6% | +6.7% | +0.9% |
| 180 days | +16.3% | +11.7% | +4.6% |
Past results only. Not a forecast.
Traded Feb 24 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 24 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Feb 24 · filed 2 days laterNot under a reported trading plan
The CFO of Timken sold $168K of Timken shares. The filing does not indicate a pre-arranged trading plan.